Soluble suppression of tumorigenicity 2 associated with atrial fibrillation detected after stroke: A retrospective study [PDF]
Heliyon, 2023 Background: The soluble suppression of tumorigenicity 2 (sST2) is closely associated with stroke and atrial fibrillation (AF). However, no studies on sST2 and AF detected after stroke (AFDAS) have been reported.
Suhua Qi
exaly +4 more sources
Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect [PDF]
Pulmonary Circulation, 2020 Uncorrected atrial septal defect undergoes right ventricle chronic volume overload which may lead to pulmonary hypertension and Eisenmenger Syndrome. The soluble suppression of tumorigenicity-2 is a left ventricle strain biomarker; however, its role in ...
Anggoro Budi Hartopo
exaly +3 more sources
The Soluble Suppression of Tumorigenicity 2 as a Biomarker of Early Cardiac Remodeling in Bradycardia Patients Receiving Permanent Pacemaker Therapy [PDF]
Future Science OA, 2023 Aim: This study aims to evaluate: the difference of soluble suppression of tumorigenicity 2 (sST2) level, a biomarker for cardiac remodeling and echocardiography parameters value prior to and 1 month after implantation; and the association between ...
Young Hoon Kim +2 more
exaly +4 more sources
Soluble Suppression of Tumorigenicity‐2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device [PDF]
Journal of the American Heart AssociationBackground Soluble suppression of tumorigenicity‐2 (sST2) predicts mortality in patients with heart failure. The predictive value of sST2 in patients with a left ventricular assist device remains unknown.
Nicolaas de Jonge +2 more
exaly +4 more sources
Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study [PDF]
Renal Failure, 2020 Background Both soluble suppression of tumorigenicity 2 (sST2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) are promising biomarkers associated with the adverse clinical outcomes of dialysis patients.
Zhiyu Wang, Wen Zhang, Xiaonong Chen
exaly +3 more sources
Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis [PDF]
Frontiers in Cardiovascular Medicine, 2023 PurposeAtrial fibrosis is the main pathological basis for the pathogenesis and progression of atrial fibrillation (AF). Soluble suppression of tumorigenicity 2 (sST2) is involved in fibrosis.
Pengfei Chen +8 more
doaj +2 more sources
Soluble Suppression of Tumorigenicity-2 Associates With Ventilator Dependence in Coronavirus Disease 2019 Respiratory Failure [PDF]
Critical Care Explorations, 2021 OBJECTIVES:. We hypothesize that elevated soluble suppression of tumorigenicity-2 concentrations, a marker of pulmonary epithelial injury, reflect ongoing lung injury in acute hypoxemic respiratory failure due to coronavirus disease 2019 and associate ...
Jehan W. Alladina, MD +10 more
doaj +2 more sources
Circulating Soluble Suppression of Tumorigenicity 2 Predicts Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation [PDF]
Frontiers in Cardiovascular Medicine, 2021 Objective: A more extensively fibrotic left atrium contributes to atrial fibrillation (AF) occurrence, persistence, and recurrence. The soluble suppression of tumorigenicity 2 (sST2) has emerged as a ventricular fibrotic biomarker for patients with heart
Ruopeng Tan +8 more
doaj +2 more sources
Soluble suppression of tumorigenicity 2 associated with major adverse cardiac events in children with myocarditis [PDF]
Frontiers in Cardiovascular MedicineObjectiveSoluble suppression of tumorigenicity 2 (sST2) is associated with the prognosis of some cardiac diseases, but studies on sST2 and the prognosis of patients with myocarditis are rare. This study investigated the relationship between major adverse
Tongtong Shi +3 more
doaj +2 more sources
Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study [PDF]
Scientific Reports, 2021 Prognostication after cardiopulmonary resuscitation (CPR) is complex. Novel biomarkers like soluble suppression of tumorigenicity 2 (sST2) may provide an objective approach.
Richard Rezar +13 more
doaj +2 more sources